Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

被引:236
作者
Marais, Ben J. [1 ,2 ]
Loennroth, Knut [3 ]
Lawn, Stephen D. [4 ,5 ]
Migliori, Giovanni Battista [6 ]
Mwaba, Peter [7 ,8 ]
Glaziou, Philippe [3 ]
Bates, Matthew [7 ,25 ]
Colagiuri, Ruth [10 ]
Zijenah, Lynn [9 ]
Swaminathan, Soumya [11 ]
Memish, Ziad A. [12 ,13 ]
Pletschette, Michel [14 ]
Hoelscher, Michael [15 ]
Abubakar, Ibrahim [17 ,18 ]
Hasan, Rumina [16 ]
Zafar, Afia [16 ]
Pantaleo, Guiseppe [19 ]
Craig, Gill [20 ]
Kim, Peter [21 ]
Maeurer, Markus [22 ,23 ]
Schito, Marco [24 ]
Zumla, Alimuddin [7 ,25 ]
机构
[1] Univ Sydney, Sydney Emerging Infect & Biosecur Inst, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sydney Med Sch, Childrens Hosp Westmead, Sydney, NSW 2006, Australia
[3] WHO, StopTB Dept, CH-1211 Geneva, Switzerland
[4] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England
[5] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa
[6] WHO Collaborating Ctr TB & Lung Dis, Fdn S Maugeri, Care & Res Inst, Tradate, Italy
[7] Univ Zambia Univ Coll London Med Sch UNZA UCLMS, Res & Training Project, Univ Teaching Hosp, Lusaka, Zambia
[8] Minist Hlth, Lusaka, Zambia
[9] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[10] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Hlth & Sustainabil Unit, Sydney, NSW 2006, Australia
[11] Natl Inst Res TB, Madras, Tamil Nadu, India
[12] Minist Hlth, Riyadh, Saudi Arabia
[13] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
[14] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland
[15] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany
[16] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan
[17] Hlth Protect Agcy, London, England
[18] UCL, Dept Infect & Populat Hlth, Ctr Infect Dis Epidemiol, London, England
[19] Univ Lausanne, Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland
[20] City Univ London, Sch Hlth Sci, London EC1V 0HB, England
[21] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA
[22] Karolinska Inst, Div Therapeut Immunol LabMed & Microbiol Tumor &, Stockholm, Sweden
[23] Karolinska Hosp, Ctr Allogene Stem Cell Transplantat, S-10401 Stockholm, Sweden
[24] NIAID, Henry M Jackson Fdn, Div Aids, NIH, Bethesda, MD 20892 USA
[25] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会; 英国惠康基金; 美国国家卫生研究院;
关键词
SUB-SAHARAN AFRICA; DIABETES-MELLITUS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; SOCIAL DETERMINANTS; MATERNAL MORTALITY; INFECTIOUS-DISEASES; TREATMENT OUTCOMES; MIDDLE-INCOME; GLOBAL BURDEN;
D O I
10.1016/S1473-3099(13)70015-X
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Recent data for the global burden of disease reflect major demographic and lifestyle changes, leading to a rise in noncommunicable diseases. Most countries with high levels of tuberculosis face a large comorbidity burden from both non-communicable and communicable diseases. Traditional disease-specific approaches typically fail to recognise common features and potential synergies in integration of care, management, and control of non-communicable and communicable diseases. In resource-limited countries, the need to tackle a broader range of overlapping comorbid diseases is growing. Tuberculosis and HIV/AIDS persist as global emergencies. The lethal interaction between tuberculosis and HIV coinfection in adults, children, and pregnant women in sub-Saharan Africa exemplifies the need for well integrated approaches to disease management and control. Furthermore, links between diabetes mellitus, smoking, alcoholism, chronic lung diseases, cancer, immunosuppressive treatment, malnutrition, and tuberculosis are well recognised. Here, we focus on interactions, synergies, and challenges of integration of tuberculosis care with management strategies for non-communicable and communicable diseases without eroding the functionality of existing national programmes for tuberculosis. The need for sustained and increased funding for these initiatives is greater than ever and requires increased political and funder commitment.
引用
收藏
页码:436 / 448
页数:13
相关论文
共 124 条
[1]
Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5
[2]
Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675
[3]
Atherosclerosis and tuberculosis:: Are they both chronic infectious diseases? [J].
Ånestad, G ;
Hoel, T ;
Scheel, O ;
Vainio, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (10) :797-797
[4]
[Anonymous], COLL FRAM CAR CONTR
[5]
[Anonymous], EXPERT REV ANTI INFE
[6]
[Anonymous], GUIDELINES USE ANTIR
[7]
[Anonymous], 2012, WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders
[8]
[Anonymous], GUID NAT TUB HIV PRO
[9]
[Anonymous], EUR RESP J
[10]
[Anonymous], 2008, INTEGRATED HLTH SERV